StockData
DexCom Inc logo

DexCom Inc

DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3032% below fair value
$80.19−2.33 (-2.82%)

Close on Nov 19, 2026Market cap $29.91BP/E 31.6Yield –

DexCom Total Allocated Share-Based Compensation Expense by Quarter

Total Allocated Share-Based Compensation Expense ($M)

DexCom Total Allocated Share-Based Compensation Expense: $36.8M in Q3 2026, down 18.4% from a year earlier.

Latest, Q3 2026
36.8
Period ended Sep 30, 2026
Change on a year earlier
-18.4%
45.1 in Q3 2025
History
35 quarters
Since Q4 2017
Sources
32
Documents cited below

Where the Q3 2026 figure comes from

Source: 10-Q (FY2026Q3, filed 2026-10-29) ↗

Reported in Form 10-K & Form 10-Q Footnotes (XBRL).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Allocated Share-Based Compensation Expense ($M)Year on yearSource
Q3 2026Sep 30, 202636.8-18.4%10-Q (FY2026Q3, filed 2026-10-29) ↗
Q2 2026Jun 30, 202639-13.9%10-Q (FY2026Q2, filed 2026-07-30) ↗
Q1 2026Mar 31, 202643.3+26.6%10-Q (FY2026Q1, filed 2026-04-30) ↗
Q4 2025Dec 31, 202535-19.2%10-K (FY2025, filed 2026-02-12) ↗
Q3 2025Sep 30, 202545.1+3.9%10-Q (FY2026Q3, filed 2026-10-29) ↗
Q2 2025Jun 30, 202545.3+1.3%10-Q (FY2026Q2, filed 2026-07-30) ↗
Q1 2025Mar 31, 202534.2-12.3%10-Q (FY2026Q1, filed 2026-04-30) ↗
Q4 2024Dec 31, 202443.3+17.3%10-K (FY2024, filed 2025-02-18) ↗
Q3 2024Sep 30, 202443.4+11.3%10-Q (FY2025Q3, filed 2025-10-30) ↗
Q2 2024Jun 30, 202444.7+12.6%10-Q (FY2025Q2, filed 2025-07-30) ↗
Q1 2024Mar 31, 202439+10.8%10-Q (FY2025Q1, filed 2025-05-01) ↗
Q4 2023Dec 31, 202336.9+8.5%10-K (FY2023, filed 2024-02-08) ↗
Q3 2023Sep 30, 202339+26.6%10-Q (FY2024Q3, filed 2024-10-24) ↗
Q2 2023Jun 30, 202339.7+21.8%10-Q (FY2024Q2, filed 2024-07-25) ↗
Q1 2023Mar 31, 202335.2+21.0%10-Q (FY2024Q1, filed 2024-04-25) ↗
Q4 2022Dec 31, 202234+29.3%10-K (FY2022, filed 2023-02-09) ↗

Breakdown

What makes up total Allocated Share-Based Compensation Expense

Cite this data

StockData. (2026). DexCom Total Allocated Share-Based Compensation Expense ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from DexCom SEC filings and investor materials. https://stockdatahq.com/stocks/dxcm/kpis/sbc-alloc-total

See every metric in the DexCom KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?